Health TrialsbyHealthPanel

The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.

ConditionHypertension
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55+
SponsorTexas Southern University

About this trial

The proposed study, "Check, Monitor, Control Hypertension in Older African American Adults," is a randomized clinical trial designed to improve blood pressure control among African American adults aged 55 years and older in the Greater Houston area. Hypertension disproportionately affects African Americans, contributing to higher rates of cardiovascular disease and stroke. This project aims to improve clinical and behavioral outcomes through a 24-month intervention combining pharmacist-led counseling and Community Health Worker (CHW) support.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

55 years or older

Have at least 2 high blood pressure readings ≥ 130/80 mmHg within one month

Past Medical History of hypertension > 1 year

Taking at least 1 antihypertensive medication

Disqualifiers

Unable to verbalize comprehension of study or impaired cognitive function (e.g. dementia)

Not able to monitor blood pressure at home

Plans to relocate outside Houston within the next year

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pharmacists Only (Control Group)

    Other intervention

    Medication management and disease state counseling provided by a clinical pharmacist.

  • Combined Intervention (Pharmacists + CHW Interventions)

    Other intervention

    Participants receive CHW Individual patient assistance and group health workshops in addition to pharmacist interventions

Treatment groups

480 Participants
are divided into 2 treatment groups
Group A: Pharmacist Only (Control Group)Active comparator 1 intervention
Group B: Combined Intervention (Pharmacists + CHW Interventions)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change in Systolic Blood Pressure

Mean change in systolic blood pressure (mmHg) from baseline to 24 months, measured using standardized BP readings.

Time frame
Baseline, 6 months, 12 months, 18 months, 24 months

Secondary outcomes

1

Change in Diastolic Blood Pressure

Mean change in diastolic BP from baseline to 24 months.

Time frame
Baseline, 6 months, 12 months, 18 months, 24 months
2

Medication Adherence

Proportion of participants adhering to prescribed antihypertensive medications, assessed via self-report.

Time frame
Baseline, 6 months, 12 months, 18 months, 24 months
3

Lifestyle Behavior Changes

Changes in diet, physical activity, and assessed via validated questionnaires.

Time frame
Baseline, 6 months, 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Texas Southern University

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Source ClinicalTrials.gov
Apply now